| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Sep 18, 2025 | Y-mAbs Therapeutics, Inc. | Director | Sell | 42.5 | -30,905 | -100.00% | ✗ | $50.1K |
| Sep 25, 2018 | Sep 26, 2018 | Y-mAbs Therapeutics, Inc. | Director | Buy | 100.0 | +430,174 | 44.69% | ✗ | $6.9M |